MI-LINEAGE-LOGISTICS
Lineage Logistics, LLC (Lineage), the world’s most innovative and trusted provider of temperature-controlled supply chain solutions, broke ground this week on a significant expansion to its Sunnyvale, Texas warehousing and distribution facility in the Dallas-Fort Worth logistics market. Harnessing the power of some of the world’s most advanced automation and robotics warehouse technologies Lineage will nearly double the pallet capacity of the current facility while occupying less than a third of its current footprint. This project helps to cement Lineage as the most innovative as well as the largest automated solution provider in the temperature-controlled warehousing industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180412005515/en/
“At Lineage, we are committed to disrupting the temperature-controlled supply chain through the use of new technology, applied sciences, and innovative thinking,” said Greg Lehmkuhl, President and CEO of Lineage Logistics. “Our expansion in Sunnyvale is another tremendous example of that commitment, and we are thrilled to deploy a number of dynamic technologies to help preserve, protect and optimize the distribution of the food products our customers entrust to us.”
The facility will be Lineage’s first fully automated development in North America and is designed to support maximum flexibility and responsiveness. Implementing a process called Dynamic Profiling, Lineage will have the ability to adapt to a wide range of customer needs in Sunnyvale over time. The facility’s Automated Storage and Retrieval Systems technology will move product seamlessly through a nine-level, 100-foot ceiling location, while the significant corresponding increase in storage density will greatly reduce energy consumption.
The expanded facility, located at 367 Long Creek Road, will add approximately 94,000 new square footage to the existing 311,885 square foot location and have the ability to house roughly 24,000 additional pallet positions. When completed, Lineage estimates that nearly 30 new jobs will be created from the local workforce to support operations.
“I would like to thank our partners within the City of Sunnyvale for their significant support in bringing this project to life,” Added Lehmkuhl. “From Mayor Phaup’s office, to the Departments of Engineering, Economic Development and others, we have had a true partner throughout the development and approval process, and they were instrumental in bringing these innovations and jobs to the local economy.”
The facility is currently under construction and is expected to begin full operation in 2019.
About Lineage Logistics: Lineage Logistics is the industry’s leading innovator in temperature-controlled supply chain and logistics. Lineage’s expertise in end-to-end logistical solutions, its unrivaled real estate network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. (www.lineagelogistics.com )
View source version on businesswire.com: https://www.businesswire.com/news/home/20180412005515/en/
Contact:
Lineage Logistics
Megan Hendricksen, 949-247-5172
mhendricksen@LineageLogistics.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 01:00:00 CET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 19:32:00 CET | Press release
First Marketing Authorization granted in France for the treatment of ricin poisoning, one of the most toxic natural substances in the world and a recognized priority biological threat. Ricimed® addresses a previously unmet medical need in the management of severe and potentially fatal ricin intoxications.Supported by the French Ministry of the Armed Forces and Veterans Affairs (the Directorate General of Armaments and the French Military Health Service), the development of Ricimed® illustrates Fabentech’s transition to a new scale and, with recent support from the European HERA Invest program, reinforces its positioning as a reference player in medical countermeasures against biological threats, serving both civilian and military markets. Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release featur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom